A Phase 2 Study of Nivolumab Plus Ipilimumab in Previously Treated Classical Kaposi Sarcoma (CKS)
Phase of Trial: Phase II
Latest Information Update: 02 Jan 2019
At a glance
- Drugs Ipilimumab (Primary) ; Nivolumab (Primary)
- Indications Kaposi's sarcoma
- Focus Therapeutic Use
- 23 Dec 2018 Status changed from not yet recruiting to recruiting.
- 31 Aug 2018 Biomarkers information updated
- 28 Sep 2017 Planned initiation date changed from 1 Sep 2017 to 1 Dec 2017.